ArticleClinical & translational immunology2021

The myeloid cell type I IFN system promotes antitumor immunity over pro-tumoral inflammation in cancer T-cell therapy.

Janne Ruotsalainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.